Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Immunitas Therapeutics
Arcus Biosciences, Inc.
Washington University School of Medicine
Washington University School of Medicine
University Medical Center Groningen
Celldex Therapeutics
CytomX Therapeutics
Hospices Civils de Lyon
Incyte Corporation
MultiVir, Inc.
Shenzhen BinDeBio Ltd.
Tel-Aviv Sourasky Medical Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Valerio Therapeutics
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Altor BioScience
National Cancer Institute (NCI)
Ontario Clinical Oncology Group (OCOG)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Utah
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Case Comprehensive Cancer Center